Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1996 Feb;23(2):253-7.

The frequency of cutaneous vasculitis is not increased in patients with rheumatoid arthritis treated with methotrexate

O Kaye  1 , C C Beckers, P Paquet, J E Arrese, G E Piérard, M G Malaise
Affiliations
  • PMID: 8882028

The frequency of cutaneous vasculitis is not increased in patients with rheumatoid arthritis treated with methotrexate

O Kaye et al. J Rheumatol. 1996 Feb.

Abstract

Objective: To analyse the frequency, type, and immunohistological features of clinical cutaneous vasculitis developing in patients with rheumatoid arthritis (RA) treated or not with methotrexate as well as their demographic, clinical and biological characteristics.

Methods: Ninety-one patients with RA receiving 9.5 mg/wk of methotrexate (MTX) were compared for an average observation time of 18 months to 130 matched patients with RA treated with various drugs excluding MTX.

Results: Whether receiving MTX or not, 5.4% of patients with RA developed a clinical cutaneous vasculitis. There were significant differences between both groups for 2 variables only: a higher percentage of polyneuropathies and a higher level of immune complex-plasma levels in non-MTX patients. The immunohistological analysis did not differentiate both groups.

Conclusion: The percentage of cutaneous vasculitis that developed under MTX therapy was not different from that occurring as a natural complication of longstanding severe RA.

PubMed Disclaimer

LinkOut - more resources